公开(公告)号：US4866072A

公开(公告)日：1989-09-12

申请号：US157715

申请日：1988-02-18

申请人： Alan M. Edwards ,  Richard A. Foulds

发明人： Alan M. Edwards ,  Richard A. Foulds

IPC分类号： A61K31/47

CPC分类号： A61K31/47 ,  Y10S514/851

摘要： A method of treatment of cystic fibrosis which comprises administration to a patient suffering from that condition of a therapeutically effective quantity of 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarbo xylic acid or a pharmaceutically acceptable derivative thereof.Pharmaceutically acceptable salts of the active ingredient which may be used include alkali metal salts, in particular the di-sodium salt which is known as nedocromil sodium.